1. Limmathurotsakul D, Golding N, Dance DAB, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016; 1: 15008.
2. Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg 2008; 102(suppl 1):S1–S4.
3. Sprague LD, Neubauer H. Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. J Vet Med B Infect Dis Vet Public 2004; 51: 305–320.
4. USDA, Animal and Plant Health Inspection Service. Proposal for a US national list of reportable animal diseases, July 2014. Available at: www.aphis.usda.gov/animal_health/downloads/nlrad_concept_paper.pdf. Accessed Jun 28, 2016.
5. Media Relations CDC. Conclusion of select agent inquiry into Burkholderia pseudomallei release at Tulane National Primate Research Center. Available at: www.cdc.gov/media/releases/2015/s0313-burkholderia-pseudomallei.html. Accessed Jun 28, 2016.
6. Dance DA. Editorial commentary: melioidosis in Puerto Rico: the iceberg slowly emerges. Clin Infect Dis 2015; 60: 251–253.
7. Doker TJ, Sharp TM, Rivera-Garcia B, et al. Contact investigation of melioidosis cases reveals regional endemicity in Puerto Rico. Clin Infect Dis 2015; 60: 243–250.
8. Benoit TJ, Blaney DD, Doker TJ, et al. A review of melioidosis cases in the Americas. Am J Trop Med Hyg 2015; 93: 1134–1139.
9. Holden MTG, Titball RW, Peacock SJ, et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A 2004; 101: 14240–14245.
10. Lazar Adler NR, Govan B, Cullinane M, et al. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS Microbiol Rev 2009; 33: 1079–1099.
11. Moore RA, Tuanyok A, Woods DE. Survival of Burkholderia pseudomallei in water. BMC Res Notes 2008; 1: 11.
12. Pruksachartvuthi S, Aswapokee N, Thankerngpol K. Survival of Pseudomonas pseudomallei in human phagocytes. J Med Microbiol 1990; 31: 109–114.
13. Jones AL, Beveridge TJ, Woods DE. Intracellular survival of Burkholderia pseudomallei. Infect Immun 1996; 64: 782–790.
14. Chantratita N, Wuthiekanun V, Boonbumrung K, et al. Biological relevance of colony morphology and phenotypic switching by Burkholderia pseudomallei. J Bacteriol 2007; 189: 807–817.
15. Austin CR, Goodyear AW, Bartek IL, et al. A Burkholderia pseudomallei colony variant necessary for gastric colonization. MBio 2015; 6: e02462–e14.
16. O'Brien CR, Krockenberger MB, Martin P, et al. Disseminated melioidosis in two cats. J Feline Med Surg 2003; 5: 83–89.
17. Lloyd JM, Suijdendorp P, Soutar WR. Melioidosis in a dog. Aust Vet J 1988; 65: 191–192.
18. Olds R, Lewis F. Melioidosis in a pig. Aust Vet J 1955; 31: 273–274.
19. Millan JM, Mayo M, Gal D, et al. Clinical variation in melioidosis in pigs with clonal infection following possible environmental contamination from bore water. Vet J 2007; 174: 200–202.
20. Choy JL, Mayo M, Currie BJ, et al. Animal melioidosis in Australia. Acta Trop 2000; 74: 153–158.
21. Ketterer PJ, Donald B, Rogers RJ. Bovine melioidosis in south-eastern Queensland. Aust Vet J 1975; 51: 395–398.
22. Srikitjakarn L, Sirimalaisuwan A, Khattiya R, et al. Seroprevalence of melioidosis in dairy cattle in Chiang Mai Province, northern Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 739–741.
23. Omar AR. Pathology of melioidosis in pigs, goats and a horse. J Comp Pathol 1963; 73: 359–372.
24. Stanton AT, Fletcher W, Symonds SL. Melioidosis in a horse. J Hyg (Lond) 1927; 26: 33–35.
25. Dance DAB. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp and human-animal hosts. Acta Trop 2000; 74: 159–168.
26. Goodyear A, Bielefeldt-Ohmann H, Schweizer H, et al. Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice. PLoS One 2012; 7: e37324.
27. West TE, Myers ND, Limmathurotsakul D, et al. Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice. Am J Trop Med Hyg 2010; 83: 1066–1069.
28. Lafontaine ER, Zimmerman SM, Shaffer TL, et al. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice. PLoS One 2013; 8: e76804.
29. Nelson M, Dean RE, Salguero FJ, et al. Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus). Int J Exp Pathol 2011; 92: 428–435.
30. Currie BJ, Jacups SP. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 2003; 9: 1538–1542.
31. Liu X, Pang L, Sim SH, et al. Association of melioidosis incidence with rainfall and humidity, Singapore, 2003–2012. Emerg Infect Dis 2015; 21: 159–162.
32. Ashdown LR. Nosocomial infection due to Pseudomonas pseudomallei: two cases and an epidemiologic study. Rev Infect Dis 1979; 1: 891–894.
33. Ralph A, McBride J, Currie BJ. Transmission of Burkholderia pseudomallei via breast milk in northern Australia. Pediatr Infect Dis J 2004; 23: 1169–1171.
34. Gan Y-H. Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy? J Infect Dis 2005; 192: 1845–1850.
35. Leelarasamee A. Epidemiology of melioidosis. J Infect Dis Antimicrob Agents 1986; 3: 84–93.
36. Currie BJ. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J 2003; 22: 542–550.
37. Sivalingam SP, Ulett GC, Nelson M. Models of infection. In: Ketheesan N, ed. Melioidosis: a century of observation and research. Amsterdam: Elsevier, 2012; 242–256.
38. Montúfar FE, Ochoa JE, Ortega H, et al. Melioidosis in Antioquia, Colombia: an emerging or endemic disease? A case series. Int J Infect Dis 2015; 37: 50–57.
39. Yeager JJ, Facemire P, Dabisch PA, et al. Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops). Infect Immun 2012; 80: 3332–3340.
40. Narita M, Loganathan P, Hussein A, et al. Pathological changes in goats experimentally inoculated with Pseudomonas pseudomallei. Natl Inst Anim Health Q (Tokyo) 1982; 22: 170–179.
41. Thomas AD, Forbes Faulkner JC, Norton JH, et al. Clinical and pathological observations on goats experimentally infected with Pseudomonas pseudomallei. Aust Vet J 1988; 65: 43–46.
42. Sanford JP, Moore WL. Recrudescent melioidosis: a southeast Asian legacy. Am Rev Respir Dis 1971; 104: 452–453.
43. Mackowiak PA, Smith JW. Septicemic melioidosis: occurrence following acute influenza six years after exposure in Vietnam. JAMA 1978; 240: 764–766.
44. Currie BJ, Fisher DA, Anstey NM, et al. Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 2000; 94: 301–304.
45. Ngauy V, Lemeshev Y, Sadkowski L, et al. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005; 43: 970–972.
46. Laws L, Mahoney DF. Melioidosis in animals in North Queensland. II. Melioidosis in a cow. Aust Vet J 1964; 40: 202.
47. Egerton JR. Bovine melioidosis. Aust Vet J 1964; 40: 34–35.
48. Parkes HM, Shilton CM, Jerrett IV, et al. Primary ocular melioidosis due to a single genotype of Burkholderia pseudomallei in two cats from Arnhem Land in the northern territory of Australia. J Feline Med Surg 2009; 11: 856–863.
49. Moe JB, Stedham MA, Jennings PB. Canine melioidosis: clinical observations in three military dogs in Vietnam. Am J Trop Med Hyg 1972; 21: 351–355.
50. Kasantikul T, Sommanustweechai A, Polsrila K, et al. Retrospective study on fatal melioidosis in captive zoo animals in Thailand. Transbound Emerg Dis 2016; 63: e389–e394.
51. Overtoom R, Khieu V, Hem S, et al. A first report of pulmonary melioidosis in Cambodia. Trans R Soc Trop Med Hyg 2008; 102: S21–S25.
52. Hoffmaster AR, AuCoin D, Baccam P, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis 2015; 21.
53. Felgner PL, Kayala MA, Vigil A, et al. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A 2009; 106: 13499–13504.
54. Tiyawisutsri R, Peacock SJ, Langa S, et al. Antibodies from patients with melioidosis recognize Burkholderia mallei but not Burkholderia thailandensis antigens in the indirect hemagglutination assay. J Clin Microbiol 2005; 43: 4872–4874.
55. Gilmore G, Barnes J, Ketheesan N, et al. Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis. Clin Vaccine Immunol 2007; 14: 1529–1531.
56. Alexander AD, Huxsoll DL, Warner AR, et al. Serological diagnosis of human melioidosis with indirect hemagglutination and complement fixation tests. Appl Microbiol 1970; 20: 825–833.
57. Peacock SJ, Schweizer HP, Dance DA, et al. Management of accidental laboratory exposure to Burkholderia pseudomallei and B mallei. Emerg Infect Dis 2008; 14: e2.
58. Wuthiekanun V, Chierakul W, Langa S, et al. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg 2006; 74: 1074–1075.
59. Limmathurotsakul D, Jamsen K, Arayawichanont A, et al. Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One 2010; 5: e12485.
60. Nicholls L. Melioidosis, with special reference to the dissociation of Bacillus whitmori. Br J Exp Pathol 1930; 11: 393–399.
61. Pumpuang A, Chantratita N, Wikraiphat C, et al. Survival of Burkholderia pseudomallei in distilled water for 16 years. Trans R Soc Trop Med Hyg 2011; 105: 598–600.
62. Godoy D, Randle G, Simpson AJ, et al. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol 2003; 41: 2068–2079.
63. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010; 4: e900.
64. Hayden HS, Lim R, Brittnacher MJ, et al. Evolution of Burkholderia pseudomallei in recurrent melioidosis. PLoS One 2012; 7: e36507.
65. Dance DA, Wuthiekanun V, Chaowagul W, et al. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989; 24: 295–309.
66. Schweizer HP. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Future Microbiol 2012; 7: 1389–1399.
67. White NJ, Chaowagul W, Wuthiekanun V, et al. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989; 23: 697–701.
68. Chetchotisakd P, Porramatikul S, Mootsikapun P, et al. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. Clin Infect Dis 2001; 33: 29–34.
69. Cheng AC, Fisher DA, Anstey NM, et al. Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother 2004; 48: 1763–1765.
70. Wuthiekanun V, Wongsuwan G, Pangmee S, et al. Perasafe, Virkon and bleach are bactericidal for Burkholderia pseudomallei, a select agent and the cause of melioidosis. J Hosp Infect 2011; 77: 183–184.
71. Calfee MW, Wendling M. Inactivation of Burkholderia pseudomallei on environmental surfaces using spray-applied, common liquid disinfectants. Lett Appl Microbiol 2015; 61: 418–422.
72. O'Connell HA, Rose LJ, Shams A, et al. Variability of Burkholderia pseudomallei strain sensitivities to chlorine disinfection. Appl Environ Microbiol 2009; 75: 5405–5409.
73. Howard K, Inglis TJJ. The effect of free chlorine on Burkholderia pseudomallei in potable water. Water Res 2003; 37: 4425–4432.
74. Wiersinga WJ, van der Poll T, White NJ, et al. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006; 4: 272–282.
75. Mu JJ, Cheng PY, Chen YS, et al. The occurrence of melioidosis is related to different climatic conditions in distinct topographical areas of Taiwan. Epidemiol Infect 2014; 142: 415–423.
76. Ma G, Zheng D, Cai Q, et al. Short Report: prevalence of Burkholderia pseudomallei in Guangxi, China. Epidemiol Infect 2010; 138: 37–39.
77. Smith MD, Wuthiekanun V, Walsh AL, et al. Quantitative recovery of Burkholderia pseudomallei from soil in Thailand. Trans R Soc Trop Med Hyg 1995; 89: 488–490.
78. White NJ. Melioidosis. Lancet 2003; 361: 1715–1722.
79. Thomas AD, Forbes-Faulkner J, Parker M. Isolation of Pseudomonas pseudomallei from clay layers at defined depths. Am J Epidemiol 1979; 110: 515–521.
80. Wuthiekanun V, Smith MD, White NJ, et al. Isolation of Pseudomonas pseudomallei from soil in north-eastern Thailand. Trans R Soc Trop Med Hyg 1995; 89: 41–43.
81. Kaestli M, Harrington G, Mayo M, et al. What drives the occurrence of the melioidosis bacterium Burkholderia pseudomallei in domestic gardens? PLoS Negl Trop Dis 2015; 9: e0003635.
82. Currie BJ, Mayo M, Anstey NM, et al. A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates. Am J Trop Med Hyg 2001; 65: 177–179.
83. Palasatien S, Lertsirivorakul R, Royros P, et al. Soil physicochemical properties related to the presence of Burkholderia pseudomallei. Trans R Soc Trop Med Hyg 2008; 102: S5–S9.
84. Ngamdee W, Tandhavanant S, Wikraiphat C, et al. Competition between Burkholderia pseudomallei and B thailandensis. BMC Microbiol 2015; 15: 56.
85. Inglis TJJ, Rigby P, Robertson TA, et al. Interaction between Burkholderia pseudomallei and Acanthamoeba species results in coiling phagocytosis, endamebic bacterial survival, and escape. Infect Immun 2000; 68: 1681–1686.
86. Nachiangmai N, Patamasucon P, Tipayamonthein B. Pseudomonas pseudomallei in southern Thailand. Southeast Asian J Trop Med Public Health 1985; 16: 83–87.
87. Thomas AD, Forbes-Faulkner JC. Persistence of Pseudomonas pseudomallei in soil. Aust Vet J 1981; 57: 535–536.
88. Baker AL, Ezzahir J, Gardiner C, et al. Environmental attributes influencing the distribution of Burkholderia pseudomallei in northern Australia. PLoS One 2015; 10: e0138953.
89. Chen YS, Chen SC, Chen YL, et al. Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei. Folia Microbiol (Praha) 2003; 48: 253–256.
90. Tong S, Yang S, Lu Z, et al. Laboratory investigation of ecological factors influencing the environmental presence of Burkholderia pseudomallei. Microbiol Immunol 1996; 40: 451–453.
91. Stopnisek N, Bodenhausen N, Frey B, et al. Genus-wide acid tolerance accounts for the biogeographical distribution of soil Burkholderia populations. Environ Microbiol 2014; 16: 1503–1512.
92. Strauss JM, Groves M, Mariappan M, et al. Melioidosis in Malaysia II. Distribution of Pseudomonas pseudomallei in soil and surface water. Am J Trop Med Hyg 1969; 18: 698–702.
93. Merianos A, Patel M, Lane J, et al. The 1990–1991 outbreak of melioidosis in the northern territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health 1993; 24:425–435.
94. Vongphayloth K, Rattanavong S, Moore CE, et al. Burkholderia pseudomallei detection in surface water in southern Laos using Moore's swabs. Am J Trop Med Hyg 2012; 86: 872–877.
95. Inglis TJJ, Sagripanti JL. Environmental factors that affect the survival and persistence of Burkholderia pseudomallei. Appl Environ Microbiol 2006; 72: 6865–6875.
96. Robertson J, Levy A, Inglis TJJ, et al. The survival of Burkholderia pseudomallei in liquid media. Am J Trop Med Hyg 2010; 82: 88–94.
97. Draper ADK, Mayo M, Harrington G, et al. Association of the melioidosis agent Burkholderia pseudomallei with water parameters in rural water supplies in northern Australia. Appl Environ Microbiol 2010; 76: 5305–5307.
98. Cox E. The fuzzy systems handbook: a practitioner's guide to building, using, and maintaining fuzzy systems. 2nd ed. New York: AP Professional, 1999.
99. McBratney AB, Odeh IO. Application of fuzzy sets in soil science: fuzzy logic, fuzzy measurements and fuzzy decisions. Geoderma 1997; 77: 85–113.
100. Mount H, Paetzold R. The temperature regime for selected soils in the United States. Lincoln, Neb: USDA, National Soil Survey Center, 2002.
101. USDA. Burkholderia pseudomallei animal health risk assessment: an assessment of the risk of melioidosis to livestock and domestic pets resulting from the release of Burkholderia pseudomallei out of a biosafety level 3 laboratory into a breeding colony of non-human primates at the Tulane National Primate Research Center, Covington, La. Fort Collins, Colo: USDA, Animal and Plant Health Inspection Service, Veterinary Services, 2015.
102. Dance DA. Melioidosis: the tip of the iceberg? Clin Microbiol Rev 1991; 4: 52–60.
103. Koponen MA, Zlock D, Palmer DL, et al. Melioidosis: forgotten, but not gone! Arch Intern Med 1991; 151: 605–608.
104. Idris A, Rachmat RFN, Ali SM. Melioidosis: a case of sheep to human transmission. J Vet Malaysia 1998; 10: 77–79.
105. CDC, National Notifiable Disease Surveillance System. Melioidosis (Burkholderia pseudomallei) 2012 case definition. Available at: wwwn.cdc.gov/nndss/conditions/melioidosis/case-definition/2012/. Accessed Jun 29, 2016.
Advertisement